Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 6
2004 8
2005 4
2006 6
2007 7
2008 14
2009 14
2010 9
2011 8
2012 17
2013 14
2014 8
2015 17
2016 17
2017 14
2018 17
2019 16
2020 14
2021 12
2022 14
2023 11
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean rangaswamy sankaranarayanan (1 results)?
Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine.
Bhatla N, Muwonge R, Malvi SG, Joshi S, Poli URR, Lucas E, Esmy PO, Verma Y, Shah A, Zomawia E, Pimple S, Jayant K, Hingmire S, Chiwate A, Vashist S, Mishra G, Jadhav R, Siddiqi M, Anantharaman D, Panicker G, Butt J, Sankaran S, Kannan TPRA, Varghese R, Kartha P, Pillai MR, Waterboer T, Müller M, Sehr P, Unger ER, Sankaranarayanan R, Basu P. Bhatla N, et al. Among authors: sankaranarayanan r. Hum Vaccin Immunother. 2023 Dec 15;19(3):2289242. doi: 10.1080/21645515.2023.2289242. Epub 2023 Dec 11. Hum Vaccin Immunother. 2023. PMID: 38078840 Free PMC article.
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial.
Sharma H, Parekh S, Pujari P, Shewale S, Desai S, Bhatla N, Joshi S, Pimple S, Kawade A, Balasubramani L, Thomas A, Suri V, Lalwani S, Uday R, Kamath V, Mandal R, Rajeswar A, Peedicayil A, Poli UR, Banerjee D, Sankaranarayanan R, Basu P, Muwonge R, Gairola S, Dogar V, Rao H, Shaligram U. Sharma H, et al. Among authors: sankaranarayanan r. Lancet Oncol. 2023 Dec;24(12):1321-1333. doi: 10.1016/S1470-2045(23)00480-1. Epub 2023 Nov 7. Lancet Oncol. 2023. PMID: 37949086 Clinical Trial.
Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in India.
M de Carvalho T, Man I, Georges D, Saraswati LR, Bhandari P, Kataria I, Siddiqui M, Muwonge R, Lucas E, Sankaranarayanan R, Basu P, Berkhof J, Bogaards JA, Baussano I. M de Carvalho T, et al. Among authors: sankaranarayanan r. BMJ Glob Health. 2023 Nov;8(11):e012580. doi: 10.1136/bmjgh-2023-012580. BMJ Glob Health. 2023. PMID: 37931940 Free PMC article.
Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries.
Soerjomataram I, Cabasag C, Bardot A, Fidler-Benaoudia MM, Miranda-Filho A, Ferlay J, Parkin DM, Ranganathan R, Piñeros M, Znaor A, Mery L, Joko-Fru YW, Dikshit R, Sankaranarayanan R, Swaminathan R, Bray F; SURVCAN-3 collaborators. Soerjomataram I, et al. Among authors: sankaranarayanan r. Lancet Oncol. 2023 Jan;24(1):22-32. doi: 10.1016/S1470-2045(22)00704-5. Lancet Oncol. 2023. PMID: 36603919
Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination.
Joshi S, Anantharaman D, Muwonge R, Bhatla N, Panicker G, Butt J, Rani Reddy Poli U, Malvi SG, Esmy PO, Lucas E, Verma Y, Shah A, Zomawia E, Pimple S, Jayant K, Hingmire S, Chiwate A, Divate U, Vashist S, Mishra G, Jadhav R, Siddiqi M, Sankaran S, Pillai Rameshwari Ammal Kannan T, Kartha P, Shastri SS, Sauvaget C, Radhakrishna Pillai M, Waterboer T, Müller M, Sehr P, Unger ER, Sankaranarayanan R, Basu P. Joshi S, et al. Among authors: sankaranarayanan r. Vaccine. 2023 Jan 4;41(1):236-245. doi: 10.1016/j.vaccine.2022.11.044. Epub 2022 Nov 26. Vaccine. 2023. PMID: 36446654 Free PMC article.
Impact of HPV vaccination on HPV-related oral infections.
Gheit T, Muwonge R, Lucas E, Galati L, Anantharaman D, McKay-Chopin S, Malvi SG, Jayant K, Joshi S, Esmy PO, Pillai MR, Basu P, Sankaranarayanan R, Tommasino M. Gheit T, et al. Among authors: sankaranarayanan r. Oral Oncol. 2023 Jan;136:106244. doi: 10.1016/j.oraloncology.2022.106244. Epub 2022 Nov 16. Oral Oncol. 2023. PMID: 36402055 Free PMC article.
IARC Perspective on Oral Cancer Prevention.
Bouvard V, Nethan ST, Singh D, Warnakulasuriya S, Mehrotra R, Chaturvedi AK, Chen TH, Ayo-Yusuf OA, Gupta PC, Kerr AR, Tilakaratne WM, Anantharaman D, Conway DI, Gillenwater A, Johnson NW, Kowalski LP, Leon ME, Mandrik O, Nagao T, Prasad VM, Ramadas K, Roitberg F, Saintigny P, Sankaranarayanan R, Santos-Silva AR, Sinha DN, Vatanasapt P, Zain RB, Lauby-Secretan B. Bouvard V, et al. Among authors: sankaranarayanan r. N Engl J Med. 2022 Nov 24;387(21):1999-2005. doi: 10.1056/NEJMsr2210097. Epub 2022 Oct 18. N Engl J Med. 2022. PMID: 36378601 No abstract available.
Effectiveness of triennial screening with clinical breast examination: 14-years follow-up outcomes of randomized clinical trial in Trivandrum, India.
Ramadas K, Basu P, Mathew BS, Muwonge R, Venugopal M, Prakasan AM, Malu R, Lucas E, Augustine P, Mony RP, Thara S, Sankaranarayanan R. Ramadas K, et al. Among authors: sankaranarayanan r. Cancer. 2023 Jan 15;129(2):272-282. doi: 10.1002/cncr.34526. Epub 2022 Nov 1. Cancer. 2023. PMID: 36321193 Free PMC article. Clinical Trial.
216 results